Antibiotic Prophylaxis for Infective Endocarditis: A Survey of Practice Among Pediatric Cardiology Providers

Clin Pediatr (Phila). 2022 Dec;61(12):859-868. doi: 10.1177/00099228221106552. Epub 2022 Jul 19.

Abstract

The 2007 American Heart Association (AHA) guidelines limited antibiotic prophylaxis (AP) for infective endocarditis (IE) to fewer patients with predisposing cardiac conditions (PCC). We surveyed the American Academy of Pediatrics Section on Cardiology and Cardiac Surgery (AAP SOCCS) on their recommendations for AP for a number of PCC and procedures. We report on those 173 respondents who follow the 2007 AHA guidelines. AP rates for high-risk PCCs clearly meeting AHA criteria ranged from 70.5-89.8%. Conversely, for PCCs which did not meet AHA criteria, prescribing rates varied from <1% to 29.5%. PCC for which AP indication was unclear per guidelines, AP rates similarly varied from 9.9-39.8%. Similar variability is noted in AP for various procedures in setting of high-risk PCC. There is variability in AP prescribing practices among pediatric cardiologists based on both underlying PCC and noncardiac procedures in the setting of underlying cardiac disease.

Keywords: congenital heart disease; endocarditis; endocarditis prophylaxis; survey.

MeSH terms

  • Antibiotic Prophylaxis / methods
  • Cardiology*
  • Child
  • Endocarditis* / prevention & control
  • Endocarditis, Bacterial* / prevention & control
  • Heart Diseases*
  • Humans
  • Surveys and Questionnaires
  • United States